Joe Rogan Experience #2578 - Calley Means

Joe says glyphosate is not used in other countries. Calley immediately corrects him: it is used in other countries. The European Commission confirms EU approval through December 15, 2033, subject to restrictions. Credit the correction; it is not an uncorrected claim by Calley.

ATSDR's 2020 profile and earlier federal studies discuss toxicity and differing cancer assessments. Recognition/inquiry predates MAHA; this does not settle cancer causation.

FDA itself has affirmed sucrose, ordinary cane or beet sugar, as generally recognized as safe by regulation. The rule allows it in food with no limit other than good manufacturing practice. Because the government already made that safety finding, food companies have no legal duty to hold studies showing that the amount of sugar in children's products, or a recommended daily amount for kids, does not harm them. This verdict would be wrong if someone found a federal rule requiring companies to keep safety studies on children's daily sugar intake.

CMS reports healthcare spending at 18.0% of US GDP in 2024, the latest historical year in its series, rather than 25%. A projected future share is not a measured current share; this statistic also does not by itself establish what caused spending growth.

EPA issued a 2017 human-health assessment and 2020 interim review decision, so it has not gone nearly 30 years without review. The 2022 court action and withdrawal mean those decisions do not settle the current dispute. Means himself immediately acknowledges a review about five years earlier; that qualification should accompany this correction.

No major poll shows anything like 90% of Americans trusting the drug industry. In Gallup's August 2025 industry ratings, 58% of Americans viewed the pharmaceutical industry negatively, and a 2023 JAMA Network Open survey found only 40% of middle-aged adults rated drug makers sometimes or always trustworthy. The speaker himself added right away that trust is declining. This verdict would be wrong if a national poll shows around 90% of Americans trust the pharmaceutical industry.

The line does not say whether it means total national spending or spending per person. On a total-spending reading, 2024 figures support a US total over three times China's: CMS reports $5.3 trillion in US national health expenditures; China's National Health Commission reports preliminary total health expenditure of 9.08955 trillion yuan. The People's Bank of China's 2024 period-average exchange rates put that at roughly $1.28 trillion. On a per-person reading, the claim is false: OECD estimates put the US at $14,885 per person and Switzerland at $9,963 (PPP), about 1.5 times. The missing denominator makes this unqualified line misleading.

FDA applies a population-level public-health standard considering users and nonusers, including youth initiation and adult cessation. That is not a statutory promise of zero harm to children, nor does it mean youth harms are ignored. The claim about internal pressure or reasons for dismissals is separate and unverified.

Joe states the broad tap-water claim and Calley agrees. Iowa's 2024 public-water report says 97.2% of 1,831 regulated systems met health-based standards. It does not establish current safety of every private well or deny serious nitrate problems. A statewide inability to drink tap water is not supported by that record.

Settlements are not scientific proof. IARC describes limited human cancer evidence, principally non-Hodgkin lymphoma, and sufficient animal evidence. That is not proof of the stronger child-specific assertion.

IARC classifies it as probably carcinogenic; EPA and European assessments differ on carcinogenicity/risk. Neither consensus that it causes human cancer nor proof of harmlessness follows. Exposure, formulation and hazard versus risk matter.

Iowa is second nationally for new cancer incidence in the 2026 state report. At about 1:11:36 Means explicitly says second and identifies Kentucky as first, correcting the earlier Iowa-first statement. His additional world and all-human-history ranking remains unsupported. State and international rates cannot be ranked by mixing crude rates or different age-standardization populations, and the map comparison does not establish glyphosate as the cause.

The Ninth Circuit vacated the human-health portion of EPA's 2020 decision in June 2022 because its analysis did not adequately support its cancer conclusion, and addressed endangered-species obligations separately. The opinion is not a judicial finding that bribery caused the review to be thrown out. Industry ghostwriting is a separate evidentiary issue; it should not be substituted for the court's actual legal reasoning.

The Ninth Circuit vacated the human-health portion of EPA's 2020 decision in June 2022 because its analysis did not adequately support its cancer conclusion, and addressed endangered-species obligations separately. The opinion is not a judicial finding that bribery caused the review to be thrown out. Industry ghostwriting is a separate evidentiary issue; it should not be substituted for the court's actual legal reasoning.

CDC estimates that 32.7% of adolescents ages 12-17 had prediabetes in 2023, not a 38% point estimate. Prediabetes is not diagnosed diabetes; Means explicitly clarifies that distinction moments later. Interpretation also depends on testing definitions and methods, so apparent changes should not automatically be treated as directly comparable time trends.

Insurer stocks have risen a lot since 2010, but not 15 times. PolitiFact found UnitedHealth, the best performer, up about 1,216 percent, which is roughly 13 times its 2010 price. The other big insurers rose about 5 to 8 times, and an industry-weighted average rose about 700 percent, or about 8 times. Stock price data showing the major insurers as a group up about 15 times since March 2010 would prove this verdict wrong.

Earlier puberty is a real trend, but this blanket number needs age, sex and a defined marker. A meta-analysis estimated breast-development onset falling 0.24 years per decade during 1977-2013. It did not establish that all American children begin puberty two to three years earlier than 50 years ago. Extrapolating its global trend to a different period is not a direct US estimate.

The historical glyphosate comparison has a basis: a 2016 study estimated that the US accounted for 19% of cumulative global glyphosate use during 1974-2014. For 2014 alone it estimated roughly 15%. Means hedges with by some measures, but this does not establish a current 20% US share of all herbicides and pesticides. Glyphosate, all pesticides, cumulative use and annual use are different denominators.

The line does not specify total national spending or spending per person. On a total-spending reading, 2024 figures support a US total over three times China's: CMS reports $5.3 trillion in US national health expenditures; China's National Health Commission reports preliminary total health expenditure of 9.08955 trillion yuan. The People's Bank of China's 2024 period-average exchange rates put that at roughly $1.28 trillion. On a per-person reading, the claim is false: OECD estimates put the US at $14,885 per person and Switzerland at $9,963 (PPP), about 1.5 times. Since the denominator is omitted, the unqualified claim is misleading rather than simply false.

The information gap is real, but the loophole was not already closed by the episode date. FDA proposed mandatory GRAS notification in August 2026, with comments due December 9; a proposal does not itself change the current voluntary notification system. That gap concerns some independently determined GRAS uses, not complete agency ignorance of all food ingredients.

The trial found 2.0% versus 2.8% protocol-defined influenza illness against a standard-dose comparator, about 0.8 percentage points absolute difference and 26.6% relative efficacy. This does not support the broad claim that it did not work. Means raises a legitimate comparator-design question for older adults; this trial does not prove superiority to every enhanced vaccine. Captions render the number as 8%, so a spoken decimal error must not be asserted without audio confirmation.

Measured NHANES data for adults 20 and older in August 2021-August 2023 report 40.3% with obesity and 32.1% overweight without obesity: 72.4% combined. Severe obesity is already included in obesity and must not be added again. The health problem is substantial, but this source does not establish an almost-80% current estimate.

Vaccine liability is restricted, not eliminated: the federal statute generally requires an eligible injury claimant to petition the compensation program before certain civil actions. Separately, Monsanto v. Durnell blocks the state failure-to-warn claim at issue through federal labeling preemption; that is narrower than immunity from every pesticide lawsuit. Neither record establishes that these are the only two protected product categories.

The United Soybean Board runs the federal soybean checkoff under USDA oversight. Federal law requires that its funds not be used to influence legislation or government action or policy, so it is not legally a lobbying group, for glyphosate or anything else. Separate groups such as the American Soybean Association do lobby on pesticide policy, so the soybean industry does push for these products, but the checkoff board is not the group that lobbies. This verdict would be wrong if records showed USB spending money to lobby for glyphosate in breach of that ban.

This comes from an older, narrower dataset. USDA studied 2011 purchases at one retailer: soft drinks ranked first among detailed commodities at 5.44% of SNAP-household spending, while candy was 15th at 2.1% in its summary categories. It tracked household purchases, including cash, not just benefits spent, and does not establish a current nationwide benefits-only ranking.

The published proposals do not show a 20-fold change in the stated concentration threshold. July specified 0.050%, equivalent to 0.5 mg/g; October specified 1 mg/g for solids or 1 mg/mL for liquids, plus a separate mitragynine-ratio condition. That concentration comparison is twofold. The earlier per-article trigger and changed definitions prevent treating this as a simple equivalent dosing allowance. These were scheduling proposals, not FDA findings of a safe consumption dose. No final 7-OH order could issue before November 13 under the October notice.

Article V permits two-thirds of state legislatures to apply for a convention to propose amendments. Congress calls it; proposed amendments require ratification by three-fourths of states. The state-initiated route avoids needing Congress to propose an amendment, but two-thirds of states cannot by themselves enact it.

Some countries do ban companies from giving money to political parties, including Canada, France and Brazil, but most do not. International IDEA's Political Finance Database has 47 of 181 countries banning corporate donations to parties and 131 with no ban, including the United Kingdom, Australia, Japan, Italy and Sweden. The same database lists the United States as already banning direct corporate donations to parties; super PACs are a separate, US-specific route. A country-by-country check showing that most democracies ban corporate money in politics would prove this verdict wrong.

The broad concern is supported, but the current number is overstated. CDC estimates 61.9% of calories among ages 1-18 in August 2021-August 2023, rather than 70%. Older studies use different years and ages; food-supply share is also different from calories actually consumed.

Means explicitly distinguishes about 5% admitting use from about 50% estimating friends use in an unnamed survey. The latter measures perceived peer behavior, not population prevalence. The 2025 National Youth Tobacco Survey estimated current e-cigarette use at 7.1% of high-school students and 5.2% of middle/high-school students combined. His separate survey cannot be verified without its questionnaire and sample.

The speaker hedged with 'I don't think,' and whether a law 'significantly' took on special interests is partly a matter of opinion. Still, the claim leaves out laws aimed squarely at that problem within the last 20 years. The Honest Leadership and Open Government Act, signed in September 2007, tightened lobbying disclosure and required reporting when lobbyists bundle campaign money, and the STOCK Act of 2012 barred members of Congress from trading on inside information. Critics argue both laws were weak, so the view is defensible, but it is one-sided. This verdict would be wrong if those laws were shown to have passed more than 20 years ago or never to have taken effect.

Pew supports money in politics as a top concern, but no matched CNBC/Fox instruments established the universal claim. Poll populations, offered responses, and 'very big problem' versus single most important issue are different measures.

No specific FDA waiver, approval-condition amendment or study identifier was established for this allegation. Means explicitly says he lacks personal insight into how the requirement was dismissed. Other ongoing trials would not resolve whether this particular condition was waived. Retain as unresolved.

The transcript contains this short interjection, but does not reliably identify the speaker. Clinical-trial deaths do not establish this categorical prediction of vaccine-caused deaths. Attribution and the exact spoken wording require audio confirmation; do not attribute it to Joe or Calley from undiarized captions.

No representative Senate time-use evidence located for the specific 90% statistic. Do not convert lack of evidence into a false verdict or substitute House member schedules.

Research using USDA survey years reports application to 79% of corn area in 2021 and 88% of soybean area in 2023. These are not 2026 estimates, so they do not conclusively refute a later change. No source was established for the episode's 99%/98% figures. Glyphosate application is distinct from genetically modified seed adoption or any-herbicide use.

A matched national child-specific estimate of 10% of calories in Spain was not established. The 2024 CORALS study examined 1,426 Spanish preschool children and used intake measures that must be distinguished from calorie share, age range and national representativeness. The prior explanation mixed grams and calories and cannot justify its precise US-Spain comparison. Retain this as unresolved until a directly comparable Spanish estimate is identified.

No national menu-frequency evidence was established showing donuts and sugary pastries rank first at school breakfast. A study of added-sugar sources answers a different question and cannot establish which food is served most often. Separately, the meal pattern allows grains or meats/meat alternates in a combined component; that supports the narrower point that a dedicated meat/egg component is not mandatory. Milk still supplies protein.

Polling data regarding the specific policy preferences of Republicans toward pesticide regulation fluctuates based on survey methodology and how the question is framed. Without access to specific recent polling data, it is impossible to confirm the claim that 92% of the demographic supports such regulation.

US child health is deteriorating, but the claim that American children rank worst for every chronic illness is not established. The 2025 JAMA study documents worsening US outcomes and compares mortality with 18 wealthy countries; it does not rank every childhood disease worldwide or across human history. Mortality includes injuries and cannot substitute for a universal disease ranking.

Not a checkable claim: Calley Means was predicting that 19 of about 20 HHS colleগues the speaker personally listed will become industry lobbyists once they leave, and a forecast about unnamed people cannot be checked yet. The broader pattern is real but smaller in published research: a 2023 Health Affairs study reported by USC Schaeffer found about 32% of 766 HHS political appointees from 2004 to 2020 later took industry jobs, and it did not count lobbyists specifically. Following those same 20 staff members' later jobs and lobbying registrations would settle it.

Determining the level of centralized control within an administration is highly subjective and depends on varying metrics of management style and executive authority. Historical comparisons are difficult to quantify objectively, and this assertion would require an exhaustive comparative analysis of staffing structures across multiple administrations to verify.

Estimates regarding the size of the kratom market vary significantly between market research firms and industry advocates. Establishing an exact dollar figure is difficult due to the lack of centralized reporting, regulatory inconsistencies, and a large informal market.